Investor Relations

Stock Quote (NASDAQ: PODD)

- 0.33
Day High:
Day Low:
2:51 PM ET on Jan 28, 2015
Delayed ~20 min. By eSignal.
Stock price graph

Corporate Profile

Insulet Corporation is an innovative medical device company based in Billerica, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through its revolutionary OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy.

Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (MDI); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. Despite these benefits, most people still choose MDI therapy largely due to the complexity, cost and inconvenience of conventional..More ▼

View all »   RSSRecent Releases

Jan 7, 2015
Insulet Strengthens Management Team to Drive Sustained Growth

Jan 7, 2015
Insulet Updates Fourth Quarter Financial Guidance

View all »Events & Presentations

Jan 14, 2015
33rd Annual J.P. Morgan Healthcare Conference
Webcast Listen to webcast

Dec 10, 2014
Insulet Corporation to Present at the Oppenheimer 25th Annual Healthcare Conference
Webcast Listen to webcast